glp 1 regulate blood sugar GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 and Anesthesia: Considerations and

Let us help you develop a safe, effective, and individualized plan for better health

Can I eat normally while taking GLP-1

A PwC study found that roughly 8-10% of US adults were using GLP-1 drugs and around 30-35% are interested in using them

Individuals with T2DM frequently have multiple cardiovascular risk factors, including obesity (32.9%), hypertension (32-80%), and dyslipidemia (39%) ( The association between glycemic control and cardiovascular outcomes in DM patients has been long studied ( To address these challenges, novel pharmacological therapies such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged, offering cardioprotective benefits ( The aim of this review is to enhance our understanding of the role of SGLT-2i and GLP-1 RAs in managing patients with T2DM and CVD

doi: 10.1016/j.expneurol.2013.11.001 [DOI] [PubMed] [Google Scholar] 182.Marxreiter F, Regensburger M, Winkler J